Founder of Vicarius Pharma AG, Hans-Peter Hasler is a Swiss businessperson who has been at the helm of 7 different companies and currently occupies the position of Non-Executive Chairman of Shield Therapeutics Plc, Chairman of Medical Imaging Analysis Center and Chairman for HBM Healthcare Investments AG. Mr. Hasler is also on the board of Minerva Neurosciences, Inc., Dr. Reddy's Laboratories SA, Vicarius Pharma AG (former Chief Executive Officer & Director) and Gain Therapeutics, Inc. and Principal at Hph Management GmbH.

Mr. Hasler previously held the position of Managing Director at Wyeth-lederle Pharma GmbH, Chief Operating Officer & Executive Vice President for Biogen, Inc. Chief Operating Officer of Biogen Idec, Inc. (North Carolina) and Executive Vice President-International at Biogen MA, Inc. (both are subsidiaries of Biogen, Inc.), Managing Director at Wyeth Pharma GmbH, Managing Director at Wyeth Pharmaceuticals AG, Chief Operating Officer of Elan Corp. Plc, Chief Marketing Officer of Wyeth Corp. and Head-Global Strategic Marketing at Wyeth Pharmaceuticals LLC.

Hans-Peter Hasler received an undergraduate degree from Schweizerisches Institut für Betriebsökonomie AG.